Huvudmeny

Home
- Fund us!
- Sarcoidosis
About Mesargen
- Goals
- Objectives
- Funders
- Funders
MESARGEN Cohorts
News
Press & Publications
- ---- Press & Publications

Submenu SV

Breadcrumb

Hem
/ News

MESARGEN News

Contact

Natalia Rivera, PhD

Center for Molecular Medicine (CMM)

Karolinska Institutet

171 77 Stockholm, Sweden

Email: contact@mesargen.org

About Mesargen

MESARGEN stands as an international consortium committed to exploring various research dimensions related to the genomics of sarcoidosis. With a commitment to rigorous scientific methodology and clinical significance, our foremost aim is to unravel the complex genetic composition of sarcoidosis and its target-organ phenotypes, also known as endophenotypes. Moreover, we endeavor to elucidate the genetic heterogeneity influencing the clinical course of sarcoidosis, explore the immunogenetic mechanisms dictating downstream effects and comorbidities, and identify prospective biomarkers crucial for accurate diagnosis and efficient treatment strategies.

Mesargen Website Cookie information

Back to top